Home
Conditions
Coagulation Protein Disorders

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

793 public trials 102 recruiting studies

Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Completed

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

NCT01260350

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Chronic Hepatitis C Infection, +10 more
Locations: Auckland Clinical Studies Ltd. Auckland, New Zealand

Christchurch Clinical Studies Trust Christchurch, New Zealand

View Trial Details

Completed

Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors

NCT01234545

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations: Algiers, Algeria

Casablanca, Morocco

Muscat, Oman

Riyadh, Saudi Arabia

View Trial Details

Completed

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors

NCT01949792

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +13 more
Locations: Madrid, Spain

View Trial Details

Completed

BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)

NCT00586521

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +10 more
Locations: Aurora, Colorado, United States

Chapel Hill, North Carolina, United States

Houston, Texas, United States

Strasbourg, France

View Trial Details

Completed

A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years

NCT02263469

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations: Samodzielny Publiczny Dzieciecy Szpital Kliniczny, Oddzial Pediatrii, Hematologii I Onkologii, ul. Marszalkowska 24, 00-576 Warsaw, Poland

Institute of Urgent and Recovery Surgery, Academy of Medical Science of Ukraine, Leninski Avenue Donetsk, Ukraine

Institute of Haematology and Transfusiology, Academy of Medical Science of Ukrainem Berlynskogo Str. Kiev, Ukraine

Institute of Blood Pathology and Transfusion Medicine, Academy of Medical Science of Ukraine, Gen. Chuprynkea Str. Lviv, Ukraine

View Trial Details

Completed

A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B

NCT02263456

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations: The Royal Free Hospital, Pond Street Hampstead, London, United Kingdom

The North Hampshire Hospital, Aldermaston Road Basingstoke, United Kingdom

Addenbrooke's Hospital, Hills Road Cambridge, United Kingdom

University Hospital of Wales, Health Park Cardiff, United Kingdom

View Trial Details

Completed

Post Marketing Observational Study of Reformulated BeneFIX

NCT00835068

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: Pfizer Investigational Site Chamberry, Cedex, France

Pfizer Investigational Site Le Chesnay, Cedex, France

Pfizer Investigational Site Caen, France

Pfizer Investigational Site Clermont-Ferrand, France

View all 17 locations

View Trial Details

Completed

Kogenate FS Regulatory Post-Marketing Surveillance

NCT01386268

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations: Many Locations, South Korea

View Trial Details

Completed

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors

NCT01921855

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations: Warsaw, Poland

Bloemfontein, Freestate, South Africa

Johannesburg, Gauteng, South Africa

London, United Kingdom

View Trial Details

Completed

Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects

NCT01272206

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations: Manchester, United Kingdom

View Trial Details

Coagulation Protein Disorders

Coagulation Protein Disorders trial results

Related conditions